This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Feb 1;28(2):206-207.

doi: 10.1093/annonc/mdw658.

Atypical autoimmune adverse effects with checkpoint blockade therapies

C F Friedman^{1

2}, A Snyder^{1

2}

Affiliations

PMID: 27993802
DOI: 10.1093/annonc/mdw658

Free article

Editorial

Atypical autoimmune adverse effects with checkpoint blockade therapies

C F Friedman et al. Ann Oncol. 2017.

Free article

. 2017 Feb 1;28(2):206-207.

doi: 10.1093/annonc/mdw658.

Authors

C F Friedman^{1

2}, A Snyder^{1

2}

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.
² Weill Cornell Medical College, New York, USA.

PMID: 27993802
DOI: 10.1093/annonc/mdw658

No abstract available

PubMed Disclaimer

Similar articles

Efficacy and safety of immune checkpoint blockade for brain metastases.
Harary M, Reardon DA, Iorgulescu JB. Harary M, et al. CNS Oncol. 2019 Jun;8(2):CNS33. doi: 10.2217/cns-2018-0018. Epub 2019 Mar 11. CNS Oncol. 2019. PMID: 30854898 Free PMC article. No abstract available.
Immune checkpoint inhibitors.
Hui E. Hui E. J Cell Biol. 2019 Mar 4;218(3):740-741. doi: 10.1083/jcb.201810035. Epub 2019 Feb 13. J Cell Biol. 2019. PMID: 30760493 Free PMC article. Review.
Adverse events associated with immune checkpoint inhibitor treatment for cancer.
Esfahani K, Meti N, Miller WH Jr, Hudson M. Esfahani K, et al. CMAJ. 2019 Jan 14;191(2):E40-E46. doi: 10.1503/cmaj.180870. CMAJ. 2019. PMID: 30642824 Free PMC article. Review. No abstract available.
Nouvelles perspectives dans l’immunothérapie des cancers.
Caux C, Bay JO. Caux C, et al. Bull Cancer. 2018 Dec;105 Suppl 1:S1-S2. doi: 10.1016/S0007-4551(18)30384-9. Bull Cancer. 2018. PMID: 30595190 French.
Checkpoint blockade after kidney transplantation.
Lesouhaitier M, Dudreuilh C, Tamain M, Kanaan N, Bailly E, Legoupil D, Deltombe C, Perrin P, Manson G, Vigneau C, Houot R. Lesouhaitier M, et al. Eur J Cancer. 2018 Jun;96:111-114. doi: 10.1016/j.ejca.2018.03.019. Epub 2018 Apr 26. Eur J Cancer. 2018. PMID: 29705511 No abstract available.

See all similar articles

Cited by

Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets.
Wang Y, Deng S, Xu J. Wang Y, et al. Cancer Biol Med. 2020 Aug 15;17(3):583-598. doi: 10.20892/j.issn.2095-3941.2020.0066. Cancer Biol Med. 2020. PMID: 32944392 Free PMC article. Review.
Impaired Anti-Tumor T cell Response in Hepatocellular Carcinoma.
Chaoul N, Mancarella S, Lupo L, Giannelli G, Dituri F. Chaoul N, et al. Cancers (Basel). 2020 Mar 8;12(3):627. doi: 10.3390/cancers12030627. Cancers (Basel). 2020. PMID: 32182707 Free PMC article.
PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology.
von Knethen A, Brüne B. von Knethen A, et al. Signal Transduct Target Ther. 2019 Jun 7;4:18. doi: 10.1038/s41392-019-0053-x. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31231553 Free PMC article. No abstract available.
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma.
Liu Y, Liu Z, Zeng X, Bai C, Chen L, Lin S, Tian X. Liu Y, et al. BMC Cancer. 2019 Dec 5;19(1):1193. doi: 10.1186/s12885-019-6372-z. BMC Cancer. 2019. PMID: 31805889 Free PMC article.
Updated Understanding of Cancer as a Metabolic and Telomere-Driven Disease, and Proposal for Complex Personalized Treatment, a Hypothesis.
Muresanu C, Somasundaram SG, Vissarionov SV, Torres Solis LF, Solís Herrera A, Kirkland CE, Aliev G. Muresanu C, et al. Int J Mol Sci. 2020 Sep 7;21(18):6521. doi: 10.3390/ijms21186521. Int J Mol Sci. 2020. PMID: 32906638 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program